ARTICLE | Company News
BioNTech, Genentech, Roche deal
September 26, 2016 7:00 AM UTC
Roche’s Genentech unit and BioNTech partnered to develop and commercialize personalized mRNA-based immunotherapies that target patient neoantigens to treat cancer. BioNTech will receive $310 million i...